Literature DB >> 25560790

The ageing patient with haemophilia.

Mariana Canaro1, Veselina Goranova-Marinova, Erik Berntorp.   

Abstract

Older patients with haemophilia (PWH) face many challenges related not only to haemophilia but also to general comorbidities associated with ageing. This article discusses the clinical experience published about the high prevalence of diseases in older PWH. These conditions are managed in the general population by healthcare workers with little training in haemophilia. Haemophilic arthropathy is common in elderly PWH. Prophylaxis starting at an early age in sufficient dose regimens to prevent arthropathy did not occur in patients who are now older than around 40 yr. Many PWH above this age thus have limitations in their activities of daily life. Cardiovascular diseases have become increasingly common in the growing, ageing cohort of PWH. Lifestyle issues such as sexual dysfunction may be exacerbated by the medical issues and psychological problems associated with haemophilia. Hepatitis C virus is a leading problem in PWH. Coinfection with HIV accelerates the progression to end-stage liver disease. Acute and chronic renal failure is more common in adult PWH than in general population. Other comorbidities are reviewed. The evidence is scarce, so it is imperative to report any experience regarding the diagnosis and treatment of these entities, to improve the quality of life of older PWH.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ageing; arthropathy; cardiovascular disease; comorbidities; haemophilia; lifestyle issues

Mesh:

Substances:

Year:  2015        PMID: 25560790     DOI: 10.1111/ejh.12497

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  Evaluation of bone mineral density and related parameters in patients with haemophilia: a single center cross-sectional study.

Authors:  Hatice Demet Kiper Unal; Melda Comert Ozkan; Fatos Dilan Atilla; Zuhal Demirci; Nur Soyer; Ilgin Yildirim Simsir; Ozgur Omur; Kazim Capaci; Guray Saydam; Fahri Sahin
Journal:  Am J Blood Res       Date:  2017-11-01

2.  Perioperative safety and hemostatic efficacy of Advate® in patients with hemophilia A in a postmarketing surveillance in Japan.

Authors:  Keiji Nogami; Hideyuki Takedani; Midori Shima; Akira Yoshioka; Tadashi Matsushita; Junki Takamatsu; Masashi Taki; Katsuyuki Fukutake; Haruhiko Uchikawa; Hiroshi Takagi; Morio Arai; Werner Engl; Akira Shirahata
Journal:  Int J Hematol       Date:  2018-03-28       Impact factor: 2.490

3.  Induction of hemodialysis with an arteriovenous fistula in a patient with hemophilia A.

Authors:  Hiroki Ishii; Chiaki Miyoshi; Keiji Hirai; Junki Morino; Saori Minato; Shohei Kaneko; Katsunori Yanai; Momoko Matsuyama; Taisuke Kitano; Mitsutoshi Shindo; Akinori Aomatsu; Hiroshi Shimoyama; Haruhisa Miyazawa; Kiyonori Ito; Yuichiro Ueda; Yoshio Kaku; Taro Hoshino; Susumu Ookawara; Yoshiyuki Morishita
Journal:  CEN Case Rep       Date:  2020-03-16

Review 4.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

5.  Mild hemophilia A presaged by recurrent postoperative hemorrhagic complications in an elderly patient.

Authors:  Hajime Ono; Taigen Sase; Hiroshi Takasuna; Yuichiro Tanaka
Journal:  Surg Neurol Int       Date:  2017-09-06

6.  Known-group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.

Authors:  Tyler W Buckner; Michael Wang; David L Cooper; Neeraj N Iyer; Christine L Kempton
Journal:  Patient Prefer Adherence       Date:  2017-10-11       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.